V. Colafrancesco

发表

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

E. Giralt, L. Steinman, I. Pertsovskaya, 2019, Neurotherapeutics.

Insulin-like growth factor-1 inhibits STS-induced cell death and increases functional recovery of in vitro differentiated neurons

M. Russo, F. Grassi, B. Pucci, 2008, Cell cycle.

NGF and VEGF Effects on Retinal Ganglion Cell Fate: New Evidence from an Animal Model of Diabetes

F. Mantelli, A. Lambiase, L. Aloe, 2014, European journal of ophthalmology.

Ocular Application of Nerve Growth Factor Protects Degenerating Retinal Ganglion Cells in a Rat Model of Glaucoma

M. Russo, S. Rossi, V. Parisi, 2011, Journal of glaucoma.

Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.

F. Crea, A. Maseri, S. Brugaletta, 2007, Journal of the American College of Cardiology.

P Acute Coronary Syndromes Persistent Activation of Nuclear Factor Kappa-B Signaling Pathway in Patients With Unstable Angina and Elevated Levels of C-Reactive Protein Evidence for a Direct Proinflammatory Effect of Azide and Lipopolysaccharide-Free C-Reactive Protein on Human Monocytes Via Nuclear

F. Crea, A. Maseri, S. Brugaletta, 2006 .

Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases.

P. Villoslada, V. Colafrancesco, 2011, Archives italiennes de biologie.

Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

V. Parisi, F. Mantelli, A. Lambiase, 2009, Proceedings of the National Academy of Sciences.

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

E. Giralt, L. Steinman, I. Pertsovskaya, 2019, Neurotherapeutics.

Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration.

S. Rossi, L. Aloe, M. Coassin, 2011, Annali dell'Istituto superiore di sanita.

Anti-NGF-antibody administration as collyrium reduces the presence of NGF and enhances the expression of VEGF in the retina, lacrimal gland and hippocampus

S. Rossi, F. Cirulli, L. Aloe, 2009, Neuroscience Letters.

Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data

M. Tsilimbaris, H. Agostini, A. Clemens, 2020, Current eye research.

Nerve Growth Factor in the Developing and Adult Lacrimal Glands of Rat With and Without Inherited Retinitis Pigmentosa

F. Mantelli, A. Lambiase, L. Aloe, 2010, Cornea.

Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

V. Parisi, F. Mantelli, A. Lambiase, 2009, Proceedings of the National Academy of Sciences.